Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q4 2023 vs. Q3 2023
How the institutions holding Sunshine Biopharma Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 11 | 15 | +4 |
| Shares | 1.31M | 2.75M | +1.44M (+110.1%) |
| Value | $415.1K | $745.7K | +$330.7K (+79.7%) |
New holders (7)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 185,255 | $50.3K | 0.00% |
| Renaissance Technologies LLC | 66,600 | $18.0K | 0.00% |
| Virtu Financial LLC | 23,862 | $6.00K | 0.00% |
| XTX Topco Ltd | 17,495 | $4.75K | 0.00% |
| Bank of America Corp | 10,000 | $2.71K | 0.00% |
| Main Street Group, LTD | 222 | $60 | 0.00% |
| Oliver Lagore Vanvalin Investment Group | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Sunshine Biopharma Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| HRT Financial LP | 18,045 | $5.00K |
| New England Capital Financial Advisors LLC | 500 | $160 |
| Morgan Stanley | 26 | $8 |